Go Pro

This company has been marked as potentially delisted and may not be actively trading.

NYSE:NEUE

NeueHealth (NEUE) Stock Price, News & Analysis

NeueHealth logo

About NeueHealth Stock (NYSE:NEUE)

Key Stats

Today's Range
$6.75
$6.75
50-Day Range
$6.58
$6.85
52-Week Range
$6.25
$6.99
Volume
N/A
Average Volume
6,683 shs
Market Capitalization
$60.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

NeueHealth is a technology‐enabled healthcare services company that partners with health plans and providers to deliver value‐based care solutions. Its core offerings include a proprietary population health management platform, risk adjustment services, patient engagement tools and care coordination support. Through data analytics and integrated care teams, NeueHealth aims to optimize outcomes for members enrolled in Medicare Advantage and other government‐sponsored plans.

Founded in 2020 and headquartered in New York, NeueHealth leverages a mix of digital outreach and live care management to identify care gaps, support chronic condition management and drive quality performance. The company’s platform integrates claims data, clinical records and member-reported information to stratify risk and guide timely interventions. By aligning incentives with its payer and provider partners, NeueHealth seeks to reduce total cost of care while improving patient satisfaction and health outcomes.

Following its merger with a special purpose acquisition company and subsequent listing on the New York Stock Exchange under the ticker NEUE, NeueHealth has expanded its footprint across the United States. The company’s leadership team comprises veteran executives from both the healthcare and technology sectors, focusing on scaling operations, enhancing its software capabilities and forging new partnerships with health systems and insurers.

AI Generated. May Contain Errors.

Receive NEUE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeueHealth and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NEUE Stock News Headlines

Elon Musk’s Hushed FCC Filing. Sept 25th.
Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the largest markets in the world. James Altucher, who previously flagged Nvidia in 2008 and Bitcoin in 2013, says the filing could rival Tesla, SpaceX and xAI combined. Few investors know this filing exists, but that is expected to change quickly.tc pixel
NeueHealth Announces Closing of Take-Private Transaction
NeueHealth Reports Second Quarter 2025 Results
See More Headlines

NEUE Stock Analysis - Frequently Asked Questions

NeueHealth, Inc. (NYSE:NEUE) released its earnings results on Thursday, August, 7th. The company reported ($1.68) earnings per share for the quarter, beating the consensus estimate of ($4.77) by $3.09. The firm earned $209.08 million during the quarter, compared to the consensus estimate of $249.50 million.
Read the conference call transcript
.

NeueHealth (NEUE) raised $1.1 billion in an initial public offering on Thursday, June 24th 2021. The company issued 51,350,000 shares at $20.00-$23.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeueHealth investors own include Jiuzi (JZXN), ARMOUR Residential REIT (ARR), Aethlon Medical (AEMD), Aditxt (ADTX), Ainos (AIMD), Adial Pharmaceuticals (ADIL) and

Company Calendar

Last Earnings
8/07/2025
Today
9/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
N/A
Current Symbol
NYSE:NEUE
Previous Symbol
NYSE:NEUE
CIK
1671284
Fax
N/A
Employees
1,252
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($15.97)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$134.68 million
Net Margins
-9.08%
Pretax Margin
-6.84%
Return on Equity
N/A
Return on Assets
-13.01%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.70
Quick Ratio
0.70

Sales & Book Value

Annual Sales
$890.44 million
Price / Sales
0.07
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($163.57) per share
Price / Book
-0.04

Miscellaneous

Outstanding Shares
9,024,000
Free Float
3,312,000
Market Cap
$60.94 million
Optionable
N/A
Beta
0.59
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NYSE:NEUE) was last updated on 9/6/2026 by MarketBeat.com Staff.
From Our Partners